Rank | Gene Set | Z-score |
---|---|---|
1 | daunorubicin metabolic process (GO:0044597) | 9.38687965 |
2 | polyketide metabolic process (GO:0030638) | 9.38687965 |
3 | doxorubicin metabolic process (GO:0044598) | 9.38687965 |
4 | ncRNA 3-end processing (GO:0043628) | 6.93316862 |
5 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.35975925 |
6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.08758813 |
7 | maintenance of protein location in nucleus (GO:0051457) | 5.83890381 |
8 | ribosomal small subunit biogenesis (GO:0042274) | 5.72446826 |
9 | regulation of response to osmotic stress (GO:0047484) | 5.42545798 |
10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.32861916 |
11 | regulation of gamma-delta T cell activation (GO:0046643) | 5.30170585 |
12 | protein localization to kinetochore (GO:0034501) | 5.24266976 |
13 | cytidine deamination (GO:0009972) | 5.08703269 |
14 | cytidine metabolic process (GO:0046087) | 5.08703269 |
15 | cytidine catabolic process (GO:0006216) | 5.08703269 |
16 | somite rostral/caudal axis specification (GO:0032525) | 5.04459611 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.02244596 |
18 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.99782016 |
19 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.93109786 |
20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.93026801 |
21 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.86957925 |
22 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.86870385 |
23 | negative regulation of telomerase activity (GO:0051974) | 4.78418922 |
24 | histone H4-K8 acetylation (GO:0043982) | 4.70173596 |
25 | histone H4-K5 acetylation (GO:0043981) | 4.70173596 |
26 | NADH metabolic process (GO:0006734) | 4.63860445 |
27 | interferon-gamma production (GO:0032609) | 4.58132227 |
28 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.56416968 |
29 | negative regulation of epidermis development (GO:0045683) | 4.41908457 |
30 | histone H4 deacetylation (GO:0070933) | 4.34733127 |
31 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.33034168 |
32 | macrophage activation involved in immune response (GO:0002281) | 4.31772498 |
33 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.25373144 |
34 | defense response to protozoan (GO:0042832) | 4.25179105 |
35 | histone H4-K12 acetylation (GO:0043983) | 4.19622827 |
36 | muscle organ morphogenesis (GO:0048644) | 4.14686285 |
37 | rRNA transcription (GO:0009303) | 4.10646118 |
38 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.08947966 |
39 | negative regulation of cell killing (GO:0031342) | 4.07421338 |
40 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.07421338 |
41 | mitotic sister chromatid segregation (GO:0000070) | 4.00072531 |
42 | B cell receptor signaling pathway (GO:0050853) | 3.98579742 |
43 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.97740344 |
44 | response to protozoan (GO:0001562) | 3.97681535 |
45 | negative regulation of interleukin-12 production (GO:0032695) | 3.95497136 |
46 | protein localization to chromosome, centromeric region (GO:0071459) | 3.90827769 |
47 | positive regulation of chemokine secretion (GO:0090197) | 3.85702539 |
48 | hormone catabolic process (GO:0042447) | 3.85059948 |
49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.82896941 |
50 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.80762756 |
51 | regulation of sister chromatid cohesion (GO:0007063) | 3.78560078 |
52 | coenzyme catabolic process (GO:0009109) | 3.75707910 |
53 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.75415155 |
54 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.74599878 |
55 | negative regulation of phagocytosis (GO:0050765) | 3.73483231 |
56 | B cell mediated immunity (GO:0019724) | 3.72510665 |
57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.71296808 |
58 | response to dietary excess (GO:0002021) | 3.69997681 |
59 | regulation of translation in response to stress (GO:0043555) | 3.69643715 |
60 | positive regulation of type 2 immune response (GO:0002830) | 3.67480278 |
61 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.67443132 |
62 | mitochondrion distribution (GO:0048311) | 3.67287594 |
63 | histone H3 deacetylation (GO:0070932) | 3.63604987 |
64 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.62336197 |
65 | nucleoside transmembrane transport (GO:1901642) | 3.60562417 |
66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.59628494 |
67 | heterochromatin organization (GO:0070828) | 3.59411942 |
68 | positive regulation of protein deacetylation (GO:0090312) | 3.55631960 |
69 | histone H4-K16 acetylation (GO:0043984) | 3.55219506 |
70 | T cell migration (GO:0072678) | 3.54945446 |
71 | cellular modified amino acid catabolic process (GO:0042219) | 3.52191145 |
72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.50789315 |
73 | regulation of energy homeostasis (GO:2000505) | 3.50203460 |
74 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.48049335 |
75 | phagocytosis, recognition (GO:0006910) | 3.47650931 |
76 | positive regulation of histone deacetylation (GO:0031065) | 3.46787240 |
77 | positive regulation of B cell differentiation (GO:0045579) | 3.45572527 |
78 | regulation of B cell differentiation (GO:0045577) | 3.44157188 |
79 | notochord development (GO:0030903) | 3.43539822 |
80 | microglial cell activation (GO:0001774) | 3.43279937 |
81 | detection of bacterium (GO:0016045) | 3.40713438 |
82 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.40639551 |
83 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.40446049 |
84 | detection of other organism (GO:0098543) | 3.40248200 |
85 | positive regulation of interferon-alpha production (GO:0032727) | 3.39393727 |
86 | positive regulation of interferon-beta production (GO:0032728) | 3.38554108 |
87 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37712543 |
88 | negative regulation of Ras GTPase activity (GO:0034261) | 3.37588425 |
89 | activated T cell proliferation (GO:0050798) | 3.36757282 |
90 | negative regulation of telomere maintenance (GO:0032205) | 3.36045203 |
91 | nuclear pore complex assembly (GO:0051292) | 3.33303025 |
92 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.31395123 |
93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.31395123 |
94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.30656047 |
95 | regulation of interferon-alpha production (GO:0032647) | 3.28068279 |
96 | chromatin assembly (GO:0031497) | 3.27245060 |
97 | response to muramyl dipeptide (GO:0032495) | 3.26656636 |
98 | sister chromatid segregation (GO:0000819) | 3.25154321 |
99 | immunoglobulin mediated immune response (GO:0016064) | 3.25002762 |
100 | T-helper 1 type immune response (GO:0042088) | 3.22797934 |
101 | transepithelial transport (GO:0070633) | 3.22011962 |
102 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.20698140 |
103 | rRNA methylation (GO:0031167) | 3.19021989 |
104 | myeloid dendritic cell differentiation (GO:0043011) | 3.18636577 |
105 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.18417355 |
106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.17838888 |
107 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.17552830 |
108 | DNA synthesis involved in DNA repair (GO:0000731) | 3.17426283 |
109 | cellular response to virus (GO:0098586) | 3.17179670 |
110 | phenol-containing compound catabolic process (GO:0019336) | 3.15110567 |
111 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.14788951 |
112 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.14095151 |
113 | inositol phosphate dephosphorylation (GO:0046855) | 3.14095151 |
114 | modulation by symbiont of host defense response (GO:0052031) | 3.13945782 |
115 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.13945782 |
116 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.13945782 |
117 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.13945782 |
118 | modulation by symbiont of host immune response (GO:0052553) | 3.13945782 |
119 | positive regulation by symbiont of host defense response (GO:0052509) | 3.13945782 |
120 | positive regulation of humoral immune response (GO:0002922) | 3.12006336 |
121 | myeloid dendritic cell activation (GO:0001773) | 3.10828024 |
122 | tachykinin receptor signaling pathway (GO:0007217) | 3.09957038 |
123 | regulation of chemokine secretion (GO:0090196) | 3.08144210 |
124 | positive regulation of macrophage cytokine production (GO:0060907) | 3.06507935 |
125 | tricarboxylic acid metabolic process (GO:0072350) | 3.06277603 |
126 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.05518511 |
127 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.05200779 |
128 | response to host immune response (GO:0052572) | 3.05200779 |
129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.05001696 |
130 | natural killer cell mediated immunity (GO:0002228) | 3.04871618 |
131 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.04871618 |
132 | 2-oxoglutarate metabolic process (GO:0006103) | 3.02866075 |
133 | pyrimidine-containing compound salvage (GO:0008655) | 3.02613597 |
134 | pyrimidine nucleoside salvage (GO:0043097) | 3.02613597 |
135 | primitive streak formation (GO:0090009) | 3.01927602 |
136 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.01496927 |
137 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.01496927 |
138 | histone H3-K4 methylation (GO:0051568) | 3.00396831 |
139 | positive regulation of granulocyte differentiation (GO:0030854) | 2.99921317 |
140 | protein import into peroxisome matrix (GO:0016558) | 2.99501722 |
141 | type I interferon signaling pathway (GO:0060337) | 2.99454040 |
142 | cellular response to type I interferon (GO:0071357) | 2.99454040 |
143 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98756761 |
144 | response to type I interferon (GO:0034340) | 2.98748304 |
145 | mRNA stabilization (GO:0048255) | 2.98286371 |
146 | RNA stabilization (GO:0043489) | 2.98286371 |
147 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97906085 |
148 | response to peptidoglycan (GO:0032494) | 2.97875962 |
149 | regulation of cilium movement (GO:0003352) | 2.97165476 |
150 | negative regulation of interleukin-6 production (GO:0032715) | 2.96518367 |
151 | regulation of apoptotic cell clearance (GO:2000425) | 2.96401717 |
152 | positive regulation of tissue remodeling (GO:0034105) | 2.96102966 |
153 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94853523 |
154 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.94387165 |
155 | positive regulation of defense response to virus by host (GO:0002230) | 2.94292750 |
156 | pre-miRNA processing (GO:0031054) | 2.93370207 |
157 | positive regulation of developmental pigmentation (GO:0048087) | 2.91485424 |
158 | quinone metabolic process (GO:1901661) | 2.90361797 |
159 | negative regulation of bone resorption (GO:0045779) | 2.90274735 |
160 | maintenance of protein localization in organelle (GO:0072595) | 2.89822178 |
161 | positive regulation of Notch signaling pathway (GO:0045747) | 2.89395553 |
162 | regulation of interferon-beta production (GO:0032648) | 2.89260364 |
163 | pore complex assembly (GO:0046931) | 2.88305778 |
164 | negative regulation of viral release from host cell (GO:1902187) | 2.87016788 |
165 | positive thymic T cell selection (GO:0045059) | 2.86986389 |
166 | regulation of interleukin-12 production (GO:0032655) | 2.86729895 |
167 | detection of external biotic stimulus (GO:0098581) | 2.86401312 |
168 | DNA replication checkpoint (GO:0000076) | 2.83959989 |
169 | establishment of endothelial barrier (GO:0061028) | 2.83739457 |
170 | retinoic acid receptor signaling pathway (GO:0048384) | 2.82192147 |
171 | intestinal epithelial cell development (GO:0060576) | 2.82130388 |
172 | modulation by symbiont of host cellular process (GO:0044068) | 2.80795476 |
173 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.79227387 |
174 | NLS-bearing protein import into nucleus (GO:0006607) | 2.78591313 |
175 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.78526798 |
176 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.78526798 |
177 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.78217442 |
178 | macrophage activation (GO:0042116) | 2.77228101 |
179 | thymic T cell selection (GO:0045061) | 2.76725789 |
180 | tolerance induction (GO:0002507) | 2.75994270 |
181 | adaptation of signaling pathway (GO:0023058) | 2.75259295 |
182 | rRNA modification (GO:0000154) | 2.74490704 |
183 | epoxygenase P450 pathway (GO:0019373) | 2.74342085 |
184 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.74230300 |
185 | vagina development (GO:0060068) | 2.73711877 |
186 | negative regulation of interleukin-2 production (GO:0032703) | 2.73361240 |
187 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.72435053 |
188 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.71256688 |
189 | positive regulation of bone resorption (GO:0045780) | 2.71229339 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.94281034 |
2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.90932815 |
3 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.59817819 |
4 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.59817819 |
5 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.59817819 |
6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.72420977 |
7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.45998538 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.03978625 |
9 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.89342141 |
10 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.63363317 |
11 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.51835413 |
12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.43856766 |
13 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.39246620 |
14 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.34606726 |
15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.32999603 |
16 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.32531647 |
17 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.25100271 |
18 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.23336887 |
19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.22378439 |
20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.19921148 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.14940068 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.13817983 |
23 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.10876740 |
24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.10139513 |
25 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.01764079 |
26 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.97715847 |
27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88920317 |
28 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.85295250 |
29 | MYB_26560356_Chip-Seq_TH2_Human | 1.82682342 |
30 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.82399363 |
31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81154398 |
32 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.81015557 |
33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80923011 |
34 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.76769095 |
35 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74112495 |
36 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.74006044 |
37 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.73033143 |
38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71024864 |
39 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.69777492 |
40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.66755596 |
41 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65265892 |
42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65211423 |
43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.65072257 |
44 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.64933369 |
45 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.64775084 |
46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64425817 |
47 | MYC_22102868_ChIP-Seq_BL_Human | 1.60416738 |
48 | MAF_26560356_Chip-Seq_TH2_Human | 1.58817916 |
49 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.58455004 |
50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.57991015 |
51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56729136 |
52 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50138674 |
53 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49848373 |
54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.47037123 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.43330937 |
56 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.42374817 |
57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.38682779 |
58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.37826260 |
59 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.37108170 |
60 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36818795 |
61 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36414722 |
62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33379193 |
63 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.33078255 |
64 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30707189 |
65 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29234959 |
66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.28922851 |
67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28534095 |
68 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.28527153 |
69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.28337554 |
70 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.28167057 |
71 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.27329312 |
72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.26586964 |
73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25936812 |
74 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24932375 |
75 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23657040 |
76 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23602905 |
77 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22689183 |
78 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.22679514 |
79 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.21590560 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21483275 |
81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20265917 |
82 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.20056350 |
83 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.19989044 |
84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18645391 |
85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17827739 |
86 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17181017 |
87 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.16888673 |
88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.15345440 |
89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14017764 |
90 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.13807816 |
91 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.13379736 |
92 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12737244 |
93 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.12058448 |
94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.11075547 |
95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10526218 |
96 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.10195968 |
97 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.09935786 |
98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09917858 |
99 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.09851934 |
100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09498367 |
101 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09054755 |
102 | GATA1_22025678_ChIP-Seq_K562_Human | 1.08767294 |
103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07858374 |
104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07507393 |
105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07479325 |
106 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06788292 |
107 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.06346623 |
108 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05816090 |
109 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05419603 |
110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.04891572 |
111 | * SMRT_27268052_Chip-Seq_Bcells_Human | 1.04572822 |
112 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03757565 |
113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03524984 |
114 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.03075741 |
115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02538407 |
116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02119594 |
117 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01533235 |
118 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.01456837 |
119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01366192 |
120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.00229670 |
121 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98935041 |
122 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98750539 |
123 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97916169 |
124 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97274386 |
125 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97005631 |
126 | MYB_26560356_Chip-Seq_TH1_Human | 0.96842500 |
127 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.96752978 |
128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95815788 |
129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95650578 |
130 | * P300_27268052_Chip-Seq_Bcells_Human | 0.95226475 |
131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94715437 |
132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94370351 |
133 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.93972764 |
134 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93770420 |
135 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93394131 |
136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.93279389 |
137 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91954616 |
138 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.91640653 |
139 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.90463434 |
140 | P68_20966046_ChIP-Seq_HELA_Human | 0.89979442 |
141 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89465207 |
142 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.89083460 |
143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89068290 |
144 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88419603 |
145 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87383909 |
146 | MAF_26560356_Chip-Seq_TH1_Human | 0.86888282 |
147 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.85934071 |
148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83884064 |
149 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.83859248 |
150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83331643 |
151 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82554510 |
152 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.81333901 |
153 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.79383232 |
154 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78270053 |
155 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.77418995 |
156 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77162978 |
157 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.77042281 |
158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76332508 |
159 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.75141360 |
160 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.75004743 |
161 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73747170 |
162 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.73657500 |
163 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.73430175 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002254_reproductive_system_inflammat | 4.91600629 |
2 | MP0003011_delayed_dark_adaptation | 3.96499249 |
3 | MP0001873_stomach_inflammation | 3.72520531 |
4 | MP0005075_abnormal_melanosome_morpholog | 3.57815383 |
5 | MP0004264_abnormal_extraembryonic_tissu | 3.49992406 |
6 | MP0005257_abnormal_intraocular_pressure | 3.24433344 |
7 | MP0000569_abnormal_digit_pigmentation | 3.15518233 |
8 | MP0004858_abnormal_nervous_system | 2.96852088 |
9 | MP0006082_CNS_inflammation | 2.87639422 |
10 | MP0006292_abnormal_olfactory_placode | 2.81238225 |
11 | MP0003879_abnormal_hair_cell | 2.73608278 |
12 | MP0003705_abnormal_hypodermis_morpholog | 2.63378668 |
13 | MP0003183_abnormal_peptide_metabolism | 2.61250180 |
14 | MP0002332_abnormal_exercise_endurance | 2.58244131 |
15 | MP0003890_abnormal_embryonic-extraembry | 2.56316484 |
16 | MP0003172_abnormal_lysosome_physiology | 2.47980799 |
17 | MP0008057_abnormal_DNA_replication | 2.32126649 |
18 | MP0000015_abnormal_ear_pigmentation | 2.20377266 |
19 | MP0001727_abnormal_embryo_implantation | 2.13989645 |
20 | MP0005499_abnormal_olfactory_system | 2.13252720 |
21 | MP0005394_taste/olfaction_phenotype | 2.13252720 |
22 | MP0003763_abnormal_thymus_physiology | 2.02985997 |
23 | MP0002933_joint_inflammation | 2.00077961 |
24 | MP0001835_abnormal_antigen_presentation | 1.96090958 |
25 | MP0009333_abnormal_splenocyte_physiolog | 1.93645233 |
26 | MP0002148_abnormal_hypersensitivity_rea | 1.90891614 |
27 | MP0001851_eye_inflammation | 1.90428166 |
28 | MP0001533_abnormal_skeleton_physiology | 1.85668720 |
29 | MP0010352_gastrointestinal_tract_polyps | 1.76575055 |
30 | MP0004381_abnormal_hair_follicle | 1.76187785 |
31 | MP0003300_gastrointestinal_ulcer | 1.69498774 |
32 | MP0008961_abnormal_basal_metabolism | 1.69453886 |
33 | MP0006035_abnormal_mitochondrial_morpho | 1.68598890 |
34 | MP0003724_increased_susceptibility_to | 1.66671415 |
35 | MP0003436_decreased_susceptibility_to | 1.64545762 |
36 | MP0005058_abnormal_lysosome_morphology | 1.58806093 |
37 | MP0002998_abnormal_bone_remodeling | 1.57377288 |
38 | MP0002277_abnormal_respiratory_mucosa | 1.56943179 |
39 | MP0002138_abnormal_hepatobiliary_system | 1.56129083 |
40 | MP0002396_abnormal_hematopoietic_system | 1.55271946 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.50906141 |
42 | MP0001545_abnormal_hematopoietic_system | 1.50906141 |
43 | MP0004957_abnormal_blastocyst_morpholog | 1.49205158 |
44 | MP0001790_abnormal_immune_system | 1.44229049 |
45 | MP0005387_immune_system_phenotype | 1.44229049 |
46 | MP0001845_abnormal_inflammatory_respons | 1.42650076 |
47 | MP0005464_abnormal_platelet_physiology | 1.41669131 |
48 | MP0001800_abnormal_humoral_immune | 1.41404893 |
49 | MP0005380_embryogenesis_phenotype | 1.39298974 |
50 | MP0001672_abnormal_embryogenesis/_devel | 1.39298974 |
51 | MP0000372_irregular_coat_pigmentation | 1.37288394 |
52 | MP0001663_abnormal_digestive_system | 1.35115862 |
53 | MP0005000_abnormal_immune_tolerance | 1.33116434 |
54 | MP0003448_altered_tumor_morphology | 1.31199665 |
55 | MP0002088_abnormal_embryonic_growth/wei | 1.30271893 |
56 | MP0003122_maternal_imprinting | 1.30053110 |
57 | MP0008469_abnormal_protein_level | 1.28822043 |
58 | MP0003984_embryonic_growth_retardation | 1.27181287 |
59 | MP0003121_genomic_imprinting | 1.26911759 |
60 | MP0009764_decreased_sensitivity_to | 1.26499637 |
61 | MP0001849_ear_inflammation | 1.25367895 |
62 | MP0000703_abnormal_thymus_morphology | 1.22376719 |
63 | MP0002452_abnormal_antigen_presenting | 1.19437052 |
64 | MP0009840_abnormal_foam_cell | 1.17499369 |
65 | MP0005310_abnormal_salivary_gland | 1.16636243 |
66 | MP0005025_abnormal_response_to | 1.15411985 |
67 | MP0002092_abnormal_eye_morphology | 1.15291719 |
68 | MP0000689_abnormal_spleen_morphology | 1.14797130 |
69 | MP0010155_abnormal_intestine_physiology | 1.14750716 |
70 | MP0003938_abnormal_ear_development | 1.10532320 |
71 | MP0001293_anophthalmia | 1.09760755 |
72 | MP0000685_abnormal_immune_system | 1.09097386 |
73 | MP0002723_abnormal_immune_serum | 1.09000999 |
74 | MP0000371_diluted_coat_color | 1.08093824 |
75 | MP0000350_abnormal_cell_proliferation | 1.04221970 |
76 | MP0002405_respiratory_system_inflammati | 1.03725274 |
77 | MP0004947_skin_inflammation | 1.03585052 |
78 | MP0009765_abnormal_xenobiotic_induced | 1.03530721 |
79 | MP0002419_abnormal_innate_immunity | 1.02615222 |
80 | MP0002653_abnormal_ependyma_morphology | 1.01586441 |
81 | MP0002722_abnormal_immune_system | 1.00688821 |
82 | MP0001819_abnormal_immune_cell | 1.00311886 |
83 | MP0003077_abnormal_cell_cycle | 1.00296055 |
84 | MP0002420_abnormal_adaptive_immunity | 0.99491460 |
85 | MP0000604_amyloidosis | 0.99019941 |
86 | MP0009278_abnormal_bone_marrow | 0.98604553 |
87 | MP0002086_abnormal_extraembryonic_tissu | 0.97180962 |
88 | MP0005671_abnormal_response_to | 0.94228010 |
89 | MP0003191_abnormal_cellular_cholesterol | 0.92682939 |
90 | MP0001915_intracranial_hemorrhage | 0.92524526 |
91 | MP0000716_abnormal_immune_system | 0.92146778 |
92 | MP0003111_abnormal_nucleus_morphology | 0.91587127 |
93 | MP0002095_abnormal_skin_pigmentation | 0.91457943 |
94 | MP0005171_absent_coat_pigmentation | 0.89709978 |
95 | MP0002398_abnormal_bone_marrow | 0.89279585 |
96 | MP0000313_abnormal_cell_death | 0.89054541 |
97 | MP0002127_abnormal_cardiovascular_syste | 0.88877061 |
98 | MP0002429_abnormal_blood_cell | 0.87843164 |
99 | MP0002139_abnormal_hepatobiliary_system | 0.86728727 |
100 | MP0000490_abnormal_crypts_of | 0.86520738 |
101 | MP0008770_decreased_survivor_rate | 0.85859611 |
102 | MP0005197_abnormal_uvea_morphology | 0.85762125 |
103 | MP0003195_calcinosis | 0.85190189 |
104 | MP0002970_abnormal_white_adipose | 0.84826223 |
105 | MP0003566_abnormal_cell_adhesion | 0.84589616 |
106 | MP0005381_digestive/alimentary_phenotyp | 0.84138751 |
107 | MP0005266_abnormal_metabolism | 0.84127668 |
108 | MP0000609_abnormal_liver_physiology | 0.81160445 |
109 | MP0002166_altered_tumor_susceptibility | 0.80692200 |
110 | MP0000343_altered_response_to | 0.80082365 |
111 | MP0004808_abnormal_hematopoietic_stem | 0.79143366 |
112 | MP0000858_altered_metastatic_potential | 0.79137594 |
113 | MP0005390_skeleton_phenotype | 0.79099941 |
114 | MP0003656_abnormal_erythrocyte_physiolo | 0.78970998 |
115 | MP0004883_abnormal_blood_vessel | 0.78867219 |
116 | MP0003303_peritoneal_inflammation | 0.78560490 |
117 | MP0005174_abnormal_tail_pigmentation | 0.78428972 |
118 | MP0005023_abnormal_wound_healing | 0.77999978 |
119 | MP0002132_abnormal_respiratory_system | 0.77011987 |
120 | MP0005319_abnormal_enzyme/_coenzyme | 0.76168419 |
121 | MP0004510_myositis | 0.75686168 |
122 | MP0008260_abnormal_autophagy | 0.74712493 |
123 | MP0000678_abnormal_parathyroid_gland | 0.74326168 |
124 | MP0002075_abnormal_coat/hair_pigmentati | 0.74221232 |
125 | MP0000383_abnormal_hair_follicle | 0.74055080 |
126 | MP0005384_cellular_phenotype | 0.71773452 |
127 | MP0001243_abnormal_dermal_layer | 0.71370803 |
128 | MP0003828_pulmonary_edema | 0.70184492 |
129 | MP0005167_abnormal_blood-brain_barrier | 0.70177124 |
130 | MP0005621_abnormal_cell_physiology | 0.69846771 |
131 | MP0009785_altered_susceptibility_to | 0.69579218 |
132 | MP0003075_altered_response_to | 0.68512160 |
133 | MP0003866_abnormal_defecation | 0.67868047 |
134 | MP0005451_abnormal_body_composition | 0.66660203 |
135 | MP0009763_increased_sensitivity_to | 0.65949904 |
136 | MP0002085_abnormal_embryonic_tissue | 0.65220068 |
137 | MP0003453_abnormal_keratinocyte_physiol | 0.64645404 |
138 | MP0002928_abnormal_bile_duct | 0.64560082 |
139 | MP0000432_abnormal_head_morphology | 0.63467886 |
140 | MP0009115_abnormal_fat_cell | 0.63219745 |
141 | MP0003091_abnormal_cell_migration | 0.63053814 |
142 | MP0001853_heart_inflammation | 0.62260646 |
143 | MP0003690_abnormal_glial_cell | 0.62231669 |
144 | MP0001324_abnormal_eye_pigmentation | 0.61842813 |
145 | MP0003787_abnormal_imprinting | 0.61193998 |
146 | MP0003795_abnormal_bone_structure | 0.60857941 |
147 | MP0001986_abnormal_taste_sensitivity | 0.59590775 |
148 | MP0003136_yellow_coat_color | 0.57710529 |
149 | MP0005220_abnormal_exocrine_pancreas | 0.55842956 |
150 | MP0000920_abnormal_myelination | 0.54726366 |
151 | MP0000249_abnormal_blood_vessel | 0.52735142 |
152 | MP0002163_abnormal_gland_morphology | 0.51119235 |
153 | MP0005379_endocrine/exocrine_gland_phen | 0.50082129 |
154 | MP0003045_fibrosis | 0.49271548 |
155 | MP0002822_catalepsy | 0.49135800 |
156 | MP0005166_decreased_susceptibility_to | 0.49073350 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Metaphyseal cupping (HP:0003021) | 7.90689111 |
2 | Striae distensae (HP:0001065) | 6.71972546 |
3 | Hypochromic microcytic anemia (HP:0004840) | 6.15953634 |
4 | Round ear (HP:0100830) | 6.07984244 |
5 | Bilateral microphthalmos (HP:0007633) | 6.07630396 |
6 | Abnormality of macular pigmentation (HP:0008002) | 5.93309585 |
7 | Cupped ribs (HP:0000887) | 5.74527579 |
8 | Constricted visual fields (HP:0001133) | 5.72357796 |
9 | Cone-rod dystrophy (HP:0000548) | 5.40953004 |
10 | Volvulus (HP:0002580) | 5.10934805 |
11 | Hepatoblastoma (HP:0002884) | 4.68857747 |
12 | Toxemia of pregnancy (HP:0100603) | 4.44797970 |
13 | Multiple enchondromatosis (HP:0005701) | 4.36432226 |
14 | Attenuation of retinal blood vessels (HP:0007843) | 4.08214785 |
15 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.07340959 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.93358861 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.93358861 |
18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.93358861 |
19 | Abnormality of the lower motor neuron (HP:0002366) | 3.91711487 |
20 | Rib fusion (HP:0000902) | 3.79061851 |
21 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.75552719 |
22 | Ependymoma (HP:0002888) | 3.69795808 |
23 | Gastrointestinal stroma tumor (HP:0100723) | 3.64043658 |
24 | Chromsome breakage (HP:0040012) | 3.44035957 |
25 | Mediastinal lymphadenopathy (HP:0100721) | 3.37282413 |
26 | Upper motor neuron abnormality (HP:0002127) | 3.37147412 |
27 | Ovoid vertebral bodies (HP:0003300) | 3.22977049 |
28 | Hypoplasia of the fovea (HP:0007750) | 3.21172402 |
29 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.21172402 |
30 | Oligodontia (HP:0000677) | 3.19749046 |
31 | Eczematoid dermatitis (HP:0000976) | 3.18336111 |
32 | Inflammation of the large intestine (HP:0002037) | 3.17586103 |
33 | Neoplasm of striated muscle (HP:0009728) | 3.17158459 |
34 | Recurrent sinusitis (HP:0011108) | 3.16812611 |
35 | Hematochezia (HP:0002573) | 3.16374613 |
36 | Femoral bowing (HP:0002980) | 3.13371572 |
37 | Large earlobe (HP:0009748) | 3.10089016 |
38 | Tibial bowing (HP:0002982) | 3.09438890 |
39 | Intestinal fistula (HP:0100819) | 3.08982251 |
40 | Testicular atrophy (HP:0000029) | 3.02159823 |
41 | Abnormality of macrophages (HP:0004311) | 3.00061488 |
42 | Gastrointestinal inflammation (HP:0004386) | 2.99371061 |
43 | Progressive visual loss (HP:0000529) | 2.98777476 |
44 | Vasculitis (HP:0002633) | 2.97604628 |
45 | Albinism (HP:0001022) | 2.96896424 |
46 | Broad nasal tip (HP:0000455) | 2.96408897 |
47 | Lack of skin elasticity (HP:0100679) | 2.95109677 |
48 | Rhabdomyosarcoma (HP:0002859) | 2.94069081 |
49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.91790939 |
50 | Obstructive lung disease (HP:0006536) | 2.91790939 |
51 | IgM deficiency (HP:0002850) | 2.91248580 |
52 | Recurrent otitis media (HP:0000403) | 2.90693152 |
53 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.90508063 |
54 | Colitis (HP:0002583) | 2.89675550 |
55 | Rectovaginal fistula (HP:0000143) | 2.89604179 |
56 | Rectal fistula (HP:0100590) | 2.89604179 |
57 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.88998357 |
58 | Abnormality of the salivary glands (HP:0010286) | 2.86512303 |
59 | Fused cervical vertebrae (HP:0002949) | 2.86491098 |
60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79693942 |
61 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79057769 |
62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.78336454 |
63 | Meningitis (HP:0001287) | 2.78223565 |
64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.74143757 |
65 | Abnormality of lateral ventricle (HP:0030047) | 2.72236648 |
66 | Astrocytoma (HP:0009592) | 2.68721334 |
67 | Abnormality of the astrocytes (HP:0100707) | 2.68721334 |
68 | Hypochromic anemia (HP:0001931) | 2.67738796 |
69 | Recurrent fungal infections (HP:0002841) | 2.67700306 |
70 | Embryonal renal neoplasm (HP:0011794) | 2.62625860 |
71 | Coxa vara (HP:0002812) | 2.61903511 |
72 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.60226743 |
73 | Cheilitis (HP:0100825) | 2.59641703 |
74 | Restrictive lung disease (HP:0002091) | 2.58802249 |
75 | Vaginal fistula (HP:0004320) | 2.57809523 |
76 | Global brain atrophy (HP:0002283) | 2.54446305 |
77 | Severe visual impairment (HP:0001141) | 2.54323423 |
78 | Recurrent viral infections (HP:0004429) | 2.53576363 |
79 | Recurrent abscess formation (HP:0002722) | 2.49101774 |
80 | Agammaglobulinemia (HP:0004432) | 2.47011546 |
81 | Partial duplication of thumb phalanx (HP:0009944) | 2.45251110 |
82 | Anomalous pulmonary venous return (HP:0010772) | 2.42032945 |
83 | Supernumerary nipples (HP:0002558) | 2.41402667 |
84 | Gingivitis (HP:0000230) | 2.40698978 |
85 | Systemic lupus erythematosus (HP:0002725) | 2.39876369 |
86 | Combined immunodeficiency (HP:0005387) | 2.37793870 |
87 | Emphysema (HP:0002097) | 2.36332273 |
88 | Impulsivity (HP:0100710) | 2.35641243 |
89 | Abnormal cartilage morphology (HP:0002763) | 2.33064949 |
90 | Abnormality of the fovea (HP:0000493) | 2.32989810 |
91 | Widely spaced teeth (HP:0000687) | 2.31674839 |
92 | Orchitis (HP:0100796) | 2.31539255 |
93 | Reduced antithrombin III activity (HP:0001976) | 2.31276732 |
94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.30283510 |
95 | Horizontal nystagmus (HP:0000666) | 2.29899373 |
96 | Cellulitis (HP:0100658) | 2.29428745 |
97 | Hand muscle atrophy (HP:0009130) | 2.25485518 |
98 | Dysostosis multiplex (HP:0000943) | 2.24548775 |
99 | Recurrent skin infections (HP:0001581) | 2.24526718 |
100 | Hepatosplenomegaly (HP:0001433) | 2.24494457 |
101 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.24240458 |
102 | Prolonged bleeding time (HP:0003010) | 2.22955303 |
103 | Blepharitis (HP:0000498) | 2.22784761 |
104 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.22605848 |
105 | Villous atrophy (HP:0011473) | 2.22605848 |
106 | Recurrent bacterial skin infections (HP:0005406) | 2.21464724 |
107 | Absent frontal sinuses (HP:0002688) | 2.20195548 |
108 | Optic neuritis (HP:0100653) | 2.18049425 |
109 | Retrobulbar optic neuritis (HP:0100654) | 2.18049425 |
110 | Meckel diverticulum (HP:0002245) | 2.17853715 |
111 | Sensory axonal neuropathy (HP:0003390) | 2.17304497 |
112 | Increased connective tissue (HP:0009025) | 2.16804568 |
113 | Spastic tetraparesis (HP:0001285) | 2.16345291 |
114 | Lymphedema (HP:0001004) | 2.16031860 |
115 | Pseudobulbar signs (HP:0002200) | 2.15608884 |
116 | Upper limb muscle weakness (HP:0003484) | 2.15364449 |
117 | Pulmonary infiltrates (HP:0002113) | 2.14954266 |
118 | Amyotrophic lateral sclerosis (HP:0007354) | 2.14953053 |
119 | Short humerus (HP:0005792) | 2.14739936 |
120 | Preauricular skin tag (HP:0000384) | 2.13714783 |
121 | Preauricular pit (HP:0004467) | 2.13232869 |
122 | Periauricular skin pits (HP:0100277) | 2.13232869 |
123 | Brushfield spots (HP:0001088) | 2.12883111 |
124 | Ragged-red muscle fibers (HP:0003200) | 2.12489936 |
125 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11095709 |
126 | Lymphopenia (HP:0001888) | 2.10561474 |
127 | Generalized hypotonia (HP:0001290) | 2.10299559 |
128 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.09639628 |
129 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09264716 |
130 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09264716 |
131 | Decreased muscle mass (HP:0003199) | 2.09017004 |
132 | Increased IgE level (HP:0003212) | 2.08376524 |
133 | Abnormality of chromosome segregation (HP:0002916) | 2.07688215 |
134 | Autoimmune hemolytic anemia (HP:0001890) | 2.07569832 |
135 | Gingival bleeding (HP:0000225) | 2.07089852 |
136 | Skin nodule (HP:0200036) | 2.06867839 |
137 | Vacuolated lymphocytes (HP:0001922) | 2.06455503 |
138 | Aplasia/Hypoplasia of the earlobes (HP:0009906) | 2.06384435 |
139 | Pulmonary fibrosis (HP:0002206) | 2.06297611 |
140 | Autoimmune thrombocytopenia (HP:0001973) | 2.06238873 |
141 | Abnormality of the intrinsic pathway (HP:0010989) | 2.04879790 |
142 | Abnormality of the ileum (HP:0001549) | 2.04123486 |
143 | Hypertensive crisis (HP:0100735) | 2.02470764 |
144 | Hypopigmentation of the fundus (HP:0007894) | 2.02370012 |
145 | Partial duplication of the phalanx of hand (HP:0009999) | 2.01233541 |
146 | Shawl scrotum (HP:0000049) | 2.00266986 |
147 | Abnormality of the pulmonary veins (HP:0011718) | 1.98912009 |
148 | Premature loss of primary teeth (HP:0006323) | 1.98877138 |
149 | Abnormality of the musculature of the hand (HP:0001421) | 1.97850849 |
150 | IgA deficiency (HP:0002720) | 1.96062583 |
151 | Recurrent pneumonia (HP:0006532) | 1.94952587 |
152 | Skin tags (HP:0010609) | 1.92620548 |
153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91858923 |
154 | Glioma (HP:0009733) | 1.91014413 |
155 | Recurrent bronchitis (HP:0002837) | 1.89439172 |
156 | Myositis (HP:0100614) | 1.89415300 |
157 | Trismus (HP:0000211) | 1.89196279 |
158 | Amyloidosis (HP:0011034) | 1.89033774 |
159 | Difficulty running (HP:0009046) | 1.88441654 |
160 | Bifid tongue (HP:0010297) | 1.88118718 |
161 | Urticaria (HP:0001025) | 1.87949088 |
162 | Spontaneous hematomas (HP:0007420) | 1.86527646 |
163 | Increased cerebral lipofuscin (HP:0011813) | 1.84699709 |
164 | Tetraplegia (HP:0002445) | 1.84444651 |
165 | Papilloma (HP:0012740) | 1.83659323 |
166 | Verrucae (HP:0200043) | 1.83659323 |
167 | Upper limb amyotrophy (HP:0009129) | 1.83394198 |
168 | Distal upper limb amyotrophy (HP:0007149) | 1.83394198 |
169 | Nasal polyposis (HP:0100582) | 1.81487812 |
170 | Spinal muscular atrophy (HP:0007269) | 1.79299700 |
171 | Freckling (HP:0001480) | 1.79240617 |
172 | Hypoplastic ilia (HP:0000946) | 1.79128499 |
173 | Limited elbow extension (HP:0001377) | 1.78948827 |
174 | Truncal obesity (HP:0001956) | 1.78711774 |
175 | Ulnar bowing (HP:0003031) | 1.78710178 |
176 | Abnormality of the fingertips (HP:0001211) | 1.78677500 |
177 | Glomerulonephritis (HP:0000099) | 1.78658866 |
178 | Abnormal lung lobation (HP:0002101) | 1.78432192 |
179 | Purpura (HP:0000979) | 1.77793420 |
180 | Hyperthyroidism (HP:0000836) | 1.77702349 |
181 | Long eyelashes (HP:0000527) | 1.77592044 |
182 | Small hand (HP:0200055) | 1.76701414 |
183 | Periodontitis (HP:0000704) | 1.76444733 |
184 | Ocular albinism (HP:0001107) | 1.74779133 |
185 | Short 5th finger (HP:0009237) | 1.71541095 |
186 | Nasolacrimal duct obstruction (HP:0000579) | 1.70806661 |
187 | Leiomyosarcoma (HP:0100243) | 1.70390166 |
188 | Uterine leiomyosarcoma (HP:0002891) | 1.70390166 |
189 | Microvesicular hepatic steatosis (HP:0001414) | 1.68333194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 8.34868538 |
2 | ERN1 | 4.70293215 |
3 | GRK5 | 4.27876771 |
4 | FES | 4.18536065 |
5 | GRK6 | 3.83801496 |
6 | CSF1R | 3.33824965 |
7 | TEC | 3.08291777 |
8 | TGFBR2 | 2.61784791 |
9 | GRK1 | 2.56073997 |
10 | ADRBK2 | 2.51076072 |
11 | MAPK7 | 2.37952363 |
12 | STK10 | 2.29023994 |
13 | TTK | 2.15685799 |
14 | MATK | 2.05954732 |
15 | GRK7 | 2.05910148 |
16 | FGR | 1.90371776 |
17 | TYRO3 | 1.85023559 |
18 | WNK1 | 1.79606501 |
19 | MOS | 1.76280460 |
20 | CDK19 | 1.63067105 |
21 | BTK | 1.62969706 |
22 | RET | 1.54248155 |
23 | MAP3K10 | 1.44359187 |
24 | IKBKB | 1.36047317 |
25 | CAMK4 | 1.35644213 |
26 | MARK2 | 1.30298006 |
27 | IRAK3 | 1.26029427 |
28 | KIT | 1.21495142 |
29 | TNK2 | 1.17968356 |
30 | FGFR3 | 1.14101596 |
31 | CSK | 1.13411586 |
32 | BLK | 1.13373698 |
33 | NTRK1 | 1.13301732 |
34 | TYK2 | 1.10912056 |
35 | PRKG2 | 1.09090876 |
36 | PAK4 | 1.08156302 |
37 | CDK7 | 1.05795595 |
38 | MAP3K14 | 1.05592550 |
39 | SIK2 | 1.05275630 |
40 | HIPK2 | 0.97733826 |
41 | CDK3 | 0.94390916 |
42 | CHEK2 | 0.94030786 |
43 | TESK2 | 0.92089837 |
44 | RIPK4 | 0.86963848 |
45 | CHUK | 0.84000586 |
46 | MAP4K1 | 0.83737270 |
47 | BCKDK | 0.82868089 |
48 | EPHA2 | 0.82143232 |
49 | MAPK12 | 0.79670436 |
50 | PRKCQ | 0.78659935 |
51 | CDC42BPA | 0.78437592 |
52 | TAOK3 | 0.77697307 |
53 | EIF2AK2 | 0.76916629 |
54 | AKT3 | 0.76720169 |
55 | MAP3K7 | 0.75022382 |
56 | MAP3K13 | 0.74377185 |
57 | MTOR | 0.70911248 |
58 | MAP2K4 | 0.70344757 |
59 | PLK1 | 0.70234656 |
60 | TXK | 0.69429033 |
61 | HCK | 0.68382902 |
62 | IRAK4 | 0.65549750 |
63 | ITK | 0.64435651 |
64 | NEK2 | 0.63535885 |
65 | PDPK1 | 0.62169813 |
66 | MAPK15 | 0.60945675 |
67 | SIK1 | 0.59920935 |
68 | TBK1 | 0.58139018 |
69 | ALK | 0.58125757 |
70 | ICK | 0.56945467 |
71 | CAMK1D | 0.56183738 |
72 | AKT2 | 0.55218828 |
73 | ADRBK1 | 0.54329359 |
74 | DDR2 | 0.54179780 |
75 | CHEK1 | 0.53869296 |
76 | RPS6KC1 | 0.53778007 |
77 | RPS6KL1 | 0.53778007 |
78 | JAK3 | 0.52601573 |
79 | RPS6KA6 | 0.52095906 |
80 | SIK3 | 0.51415568 |
81 | MAP3K11 | 0.50547179 |
82 | MAP3K1 | 0.50119414 |
83 | ERBB2 | 0.49160011 |
84 | STK4 | 0.49027679 |
85 | JAK1 | 0.48279769 |
86 | MAP2K3 | 0.48142480 |
87 | RPS6KB2 | 0.47965622 |
88 | SRC | 0.45397104 |
89 | BMX | 0.45157354 |
90 | NEK9 | 0.43341829 |
91 | BRD4 | 0.43048235 |
92 | PRKCD | 0.42994459 |
93 | FYN | 0.42545344 |
94 | JAK2 | 0.41749181 |
95 | IKBKE | 0.41210136 |
96 | PTK2 | 0.40499723 |
97 | PRKD2 | 0.40469634 |
98 | SGK2 | 0.39614694 |
99 | IGF1R | 0.39192301 |
100 | ZAP70 | 0.38106171 |
101 | PASK | 0.37917437 |
102 | LCK | 0.37652523 |
103 | IRAK1 | 0.37294382 |
104 | SYK | 0.37198155 |
105 | TLK1 | 0.36535646 |
106 | MAPK10 | 0.36527707 |
107 | IRAK2 | 0.35368156 |
108 | CAMKK1 | 0.34557871 |
109 | RPS6KA2 | 0.34270844 |
110 | PIM1 | 0.34261099 |
111 | CDK2 | 0.34182272 |
112 | FGFR4 | 0.34136819 |
113 | EGFR | 0.33752718 |
114 | MAP2K6 | 0.33422619 |
115 | PDGFRB | 0.33219394 |
116 | MAPK11 | 0.33163781 |
117 | CDK4 | 0.32402100 |
118 | MAP3K3 | 0.32220768 |
119 | GSK3A | 0.31691834 |
120 | ABL1 | 0.31188043 |
121 | INSR | 0.30675279 |
122 | TRIB3 | 0.29816005 |
123 | TAOK1 | 0.29198089 |
124 | RPS6KA1 | 0.28811304 |
125 | TTN | 0.28453600 |
126 | MAPK1 | 0.26842022 |
127 | RIPK1 | 0.26373907 |
128 | MARK3 | 0.26091520 |
129 | PKN1 | 0.26080530 |
130 | EEF2K | 0.24586721 |
131 | STK3 | 0.24347587 |
132 | TAOK2 | 0.23980238 |
133 | DAPK2 | 0.23843507 |
134 | DYRK1B | 0.23405571 |
135 | MAPK4 | 0.23353204 |
136 | ATM | 0.23193922 |
137 | EPHB1 | 0.23124522 |
138 | MAPK3 | 0.22541696 |
139 | PRKAA1 | 0.22197412 |
140 | SGK3 | 0.22116342 |
141 | STK38 | 0.19370057 |
142 | PDK1 | 0.19003327 |
143 | PRPF4B | 0.18743697 |
144 | LYN | 0.18237478 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.49514845 |
2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.04199580 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 3.32772768 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.11583552 |
5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.01489224 |
6 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.82219409 |
7 | Asthma_Homo sapiens_hsa05310 | 2.76901621 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62698653 |
9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.16788645 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03180948 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.01451529 |
12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.92029789 |
13 | Viral myocarditis_Homo sapiens_hsa05416 | 1.91903332 |
14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87036552 |
15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.83467066 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.82958703 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.82038866 |
18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80595882 |
19 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.76116705 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.71910252 |
21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.59015597 |
22 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.58062544 |
23 | Lysosome_Homo sapiens_hsa04142 | 1.57051454 |
24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55504098 |
25 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.49646427 |
26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.48022592 |
27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.45614175 |
28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.43882994 |
29 | Apoptosis_Homo sapiens_hsa04210 | 1.35838788 |
30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32406294 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.30576319 |
32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25446997 |
33 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.23278619 |
34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17921367 |
35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.17764777 |
36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.16967890 |
37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.14821853 |
38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.13182627 |
39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12536390 |
40 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.12288797 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.08656022 |
42 | Influenza A_Homo sapiens_hsa05164 | 1.07915040 |
43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05644042 |
44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99211273 |
45 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98651287 |
46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.97732108 |
47 | Malaria_Homo sapiens_hsa05144 | 0.97381750 |
48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96185474 |
49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92508514 |
50 | Prion diseases_Homo sapiens_hsa05020 | 0.90755795 |
51 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.88825394 |
52 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87565226 |
53 | Hepatitis B_Homo sapiens_hsa05161 | 0.86536488 |
54 | Hepatitis C_Homo sapiens_hsa05160 | 0.85709936 |
55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85700241 |
56 | Lysine degradation_Homo sapiens_hsa00310 | 0.85043232 |
57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.85039454 |
58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.84987766 |
59 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.84733005 |
60 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.84273952 |
61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83151548 |
62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82802638 |
63 | Measles_Homo sapiens_hsa05162 | 0.81844784 |
64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81172155 |
65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78392007 |
66 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76213542 |
67 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74931085 |
68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74795984 |
69 | Shigellosis_Homo sapiens_hsa05131 | 0.74092040 |
70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74007347 |
71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73920594 |
72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.71126537 |
73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70647189 |
74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70533326 |
75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69186897 |
76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69103583 |
77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.68760803 |
78 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66948456 |
79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65575199 |
80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64876619 |
81 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64633891 |
82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64432756 |
83 | Bladder cancer_Homo sapiens_hsa05219 | 0.63704255 |
84 | Phototransduction_Homo sapiens_hsa04744 | 0.62736439 |
85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61939314 |
86 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60934033 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.60725623 |
88 | Pertussis_Homo sapiens_hsa05133 | 0.59899890 |
89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.59193171 |
90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59085605 |
91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58985214 |
92 | Legionellosis_Homo sapiens_hsa05134 | 0.57656249 |
93 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57387328 |
94 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57318721 |
95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56779356 |
96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56040845 |
97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.55868720 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55821915 |
99 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.54990728 |
100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54296312 |
101 | Insulin resistance_Homo sapiens_hsa04931 | 0.53220829 |
102 | Alcoholism_Homo sapiens_hsa05034 | 0.52578742 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52553432 |
104 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52174704 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51248562 |
106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.50500838 |
107 | Platelet activation_Homo sapiens_hsa04611 | 0.49927432 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49585649 |
109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.48063851 |
110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48009281 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.47854719 |
112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.45479234 |
113 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.44791973 |
114 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44144515 |
115 | Prostate cancer_Homo sapiens_hsa05215 | 0.43782193 |
116 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42359626 |
117 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.42195233 |
118 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41519522 |
119 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40644685 |
120 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39699584 |
121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39520701 |
122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39465274 |
123 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38980758 |
124 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38904052 |
125 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38793056 |
126 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38676148 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.38592154 |
128 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38349021 |
129 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37068510 |
130 | Phagosome_Homo sapiens_hsa04145 | 0.36866229 |
131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36716183 |
132 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.35662820 |
133 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34993647 |
134 | Glioma_Homo sapiens_hsa05214 | 0.34848537 |
135 | Salmonella infection_Homo sapiens_hsa05132 | 0.34577955 |
136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33950369 |
137 | Colorectal cancer_Homo sapiens_hsa05210 | 0.33729769 |
138 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33492358 |
139 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.32385063 |
140 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27906655 |
141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.24514043 |